Expression of N-Acetyl Transferase Human and Human Arrest Defective 1 Proteins in Thyroid Neoplasms
- 1 October 2005
- journal article
- research article
- Published by Mary Ann Liebert Inc in Thyroid®
- Vol. 15 (10) , 1131-1136
- https://doi.org/10.1089/thy.2005.15.1131
Abstract
Protein acetylation is an important posttranslational modification regulating oncogenesis, apoptosis and cell cycle. NATH (N-acetyl transferase human) is overexpressed at the mRNA level in papillary thyroid carcinomas relative to non-neoplastic thyroid tissue. The NATH protein has recently been demonstrated to be the partner of hARD1 (human Arrest defective 1) and this complex acetylates the N-termini of proteins. ARD1 has also been implicated in the destabilization of the transcription factor HIF-1α (hypoxia inducible factor-1α). Using human thyroid papillary carcinoma biopsies and NATH- and hARD1-specific antibodies, we examined the levels of endogenous NATH and hARD1 proteins in 27 patients. We demonstrate that NATH protein level is upregulated in neoplastic versus non-neoplastic tissue in good accordance with our previous mRNA findings. In all tumors in which NATH was downregulated compared to non-neoplastic tissue, the hARD1 protein level was concomitantly reduced. SiRNA-mediated knockdown of NATH resulted in decreased levels of hARD1 protein. Taken together, these results suggest that NATH positively affects the level of hARD1 protein both in vivo and in cell cultures.Keywords
This publication has 20 references indexed in Scilit:
- Identification and characterization of the human ARD1–NATH protein acetyltransferase complexBiochemical Journal, 2005
- Expression of Matrix Metalloproteinases and Their Specific Inhibitors in Normal and Different Human Thyroid Tumor Cell LinesThyroid®, 2004
- Acetylation of proteins as novel target for antitumor therapy: Review articleAmino Acids, 2004
- Increased expression of Met protein is associated with up‐regulation of hypoxia inducible factor‐1 (HIF‐1) in tumour cells in papillary carcinoma of the thyroidThe Journal of Pathology, 2004
- Targeting HIF-1 for cancer therapyNature Reviews Cancer, 2003
- Regulation and Destabilization of HIF-1α by ARD1-Mediated AcetylationCell, 2002
- NATH, a novel gene overexpressed in papillary thyroid carcinomasOncogene, 2002
- The yeast ARD1 gene product is required for repression of cryptic mating-type information at the HML locus.Molecular and Cellular Biology, 1987
- The ARD1 gene of yeast functions in the switch between the mitotic cell cycle and alternative developmental pathwaysCell, 1985
- The Mechanism of N-Terminal Acetylation of ProteinCritical Reviews in Biochemistry, 1985